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Abstract 
Little is known about stroke with different obesity phenotype as determined using the Adult Treatment Panel-III cri-
teria with metabolic health or not. This study aimed to investigate the effects of metabolically healthy and unhealthy 
obesity on ischemic stroke in a general population. A total of 11,150 adults were examined using a multi-stage cluster 
sampling method to select a representative sample of individuals 35 years or older. Ischemic stroke was defined as 
history of a cerebrovascular event, as documented by doctors via either cranial CT or MR scan within the past 2 years. 
All subjects were categorized as having metabolically healthy non-obesity (MHNO), metabolically unhealthy non-
obesity (MUNO), metabolically healthy obesity (MHO) or metabolically unhealthy obesity (MUO) using the Adult 
Treatment Panel-III criteria. Stratified analysis were done based on different body mass index group. For the total 
population, multiple regression analyses revealed that individuals with MUNO and MUO were more likely to experi-
ence ischemic stroke compared with those with MHNO (OR 2.136, 95 % CI 1.677–2.720; OR 2.712, 95 % CI 1.798–4.092; 
all p < 0.001). The OR for ischemic stroke did not significantly differ between MHO and MHNO. Stratification based on 
different BMI group showed that, compared with people who were normal weight without Mes, participants who 
were in Mes with overweight or obesity had significantly higher OR for ischemic stroke(both p < 0.05); participants 
who were not in Mes with overweight or obesity did not showed OR significantly higher. Ischemic stroke is likely 
associated with poor metabolic health rather than with obesity itself.
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Background
Obesity has been described as a major risk factor for 
metabolic complications, such as atherosclerosis and 
cardiovascular disease (CVD), as well as stroke (Van 
Gaal and Maggioni 2014; Danaei 2014; Mahmood et  al. 
2014). Recently, a subset of obese individuals has been 
identified as metabolically healthy (MHO) (Yang et  al. 
2015). Several studies have described MHO was an obese 
phenotype that does not have the burden of metabolic 
disorder (Boonchaya-anant and Apovian 2014; Engla 
2010; Succurro et  al. 2008; Chen et  al. 2016). Based 
on this concept, metabolically unhealthy non-obesity 
(MUNO) and metabolically unhealthy obesity (MUO) 
have been identified using the Adult Treatment Panel-III 
(ATP-III) criteria (Chen et al. 2016; Geetha et al. 2011).
MHO has been found to be a lower risk factor for cor-
onary artery calcification, chronic kidney disease and 
heart failure (Chang et al. 2014; Hosny et al. 2014). Lit-
tle is known about the effects of metabolically healthy 
and unhealthy obesity on stroke. Therefore, the objec-
tive of this study was to determine the relation of 
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different obesity phenotype to ischemic stroke in a gen-
eral population with the hypothesis different phenotype 
has different influence on stroke.
Methods
Study population and sampling strategy
The methods used in this study have been previously 
published (Li et  al. 2014). This study was conducted 
between January and August 2013 using a representative 
sample of individuals residing in rural areas of Liaoning 
Province located in Northeast China. This study adopted 
a multistage, stratified, random cluster sampling scheme. 
During the first stage, three counties (Dawa, Zhangwu, 
and Liaoyang) were selected from the eastern, south-
ern, and northern regions of Liaoning Province, respec-
tively. During the second stage, one town was randomly 
selected from each county (for a total of three towns). 
Finally, during the third stage, 6–8 rural villages from 
each town were randomly selected (a total of 26 rural 
villages were included). Participants that were preg-
nant or had a malignant tumor or mental disorder were 
excluded from the study. All eligible permanent residents 
aged ≥ 35 years from each village were invited to partici-
pate in the study (a total of 14,016 participants). Of them, 
11,956 participants completed the study (85.3 % response 
rate). This study was approved by the Ethics Commit-
tee of China Medical University (Shenyang, China). All 
procedures were performed in accordance with ethi-
cal standards. Written consent was obtained from all 
participants after they were informed of the objectives, 
benefits, medical information and confidentiality agree-
ment of personal information. For participants who were 
illiterate, we obtained written informed consent from 
their proxies. Among the 11,956 participants, 706 were 
excluded from the analysis due to incomplete data. We 
used baseline data, and only participants with complete 
data on the variables analyzed in the study were included, 
resulting in a final sample size of 11,150 (5115 men and 
6035 women).
Measurements and definitions
The data collection and measurement methods used in 
this study have been described previously (Yu et al. 2014; 
Chang et al. 2016).
Information on covariates, such as demographic char-
acteristics, lifestyle risk factors, annual income and family 
history of chronic diseases, was collected during a single 
clinic visit by cardiologists and trained nurses through 
a face-to-face interview using a standard questionnaire. 
Before the survey was performed, all eligible investigators 
attended an organized training session that included the 
following subjects: the purpose of this study, the manner 
in which the questionnaire should be administered, the 
importance of standardization, the standard method of 
measurement, and the study procedures. After training, 
a strict test was used for evaluation, and only those who 
scored perfectly on the test became investigators. During 
the data collection process, a central steering committee 
in addition to a subcommittee for quality control ensured 
that all data were collected according to well-known 
standards.
Race was categorized as Han or other, which included 
some ethnic minorities in China, such as Mongol and 
Manchu. Educational level was divided into three catego-
ries, including primary school or below, middle school 
and high school or above. Self-reported sleep dura-
tion, which included nocturnal sleep and napping, was 
obtained from the questionnaire and was categorized as 
follows: ≤7, 7–8, 8–9 and >9  h/d. Annual income was 
categorized into three groups: ≤5000, 5000–20,000 and 
>20,000 CNY/year. Current drinking was defined as one 
or more alcoholic drinks in the previous year. Current 
smoking was defined as a history of 90 or more cigarettes 
and continued use.
Physical activities, which included occupational and 
leisure-time physical activities, were evaluated according 
to detailed descriptions (Hu et  al. 2010). Occupational 
and leisure-time physical activities were merged and 
regrouped into the following 3 categories: (1) low, includ-
ing light levels of both occupational and leisure-time 
physical activities; (2) moderate, including a moderate or 
high level of either occupational or leisure-time physical 
activity; and (3) high, including moderate or high levels 
of both occupational and leisure-time physical activities 
(De Backer and De 2004).
The body mass index (BMI) was calculated as weight in 
kilograms divided by the square of the height in meters. 
According to the American Heart Association guide-
lines, blood pressure (BP), which was measured three 
times at two-min intervals after more than 10  min of 
rest, was measured using a standardized automatic elec-
tronic sphygmomanometer (HEM-907; Omron, Japan). 
Caffeinated beverages and exercise were  avoided for at 
least 30  min before the measurements were performed. 
The participants were seated appropriately during the 
measurements with the arm supported at the level of the 
heart. The mean of three blood pressure (BP) measure-
ments was used in all analyses. Hypertension was defined 
as systolic blood pressure (SBP)  ≥  140  mmHg and/or 
diastolic blood pressure (DBP) ≥ 90 mmHg and/or cur-
rent use of antihypertensive medications, according to 
the JNC-7 report guidelines (Bakris et al. 2015).
Fasting blood samples, which were obtained in the 
morning after at least 12  h of fasting, were collected 
from the antecubital vein into Vacutainer tubes contain-
ing EDTA. Enzymatic reactions were used to analyze the 
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blood samples, including measurements of the fasting 
plasma glucose (FPG), high-density lipoprotein choles-
terol (HDL-C), low-density lipoprotein cholesterol (LDL-
C), triglyceride (TG), and total cholesterol (TC) levels 
and other routine blood biochemical indexes, with an 
autoanalyzer. All laboratory equipment was calibrated, 
and blinded duplicate samples were used in our study.
Definitions
We used standard operating protocols to measure ATP-
III components to define metabolic status (Chen et  al. 
2016; Manu et  al. 2012), and the cut-off point for waist 
circumference was determined based on the WHO rec-
ommendations for the Asian population (Mi et al. 2015). 
Participants with 3 or more of these criteria were consid-
ered to have unhealthy metabolism (metabolic syndrome, 
Mes); subjects who were excluded from having unhealthy 
metabolism were defined as “metabolically healthy” (1) 
BP ≥ 130/85 mmHg and/or current use of antihyperten-
sive medication; (2) WC ≥ 90 cm for men and ≥80 cm 
for women; (3) fasting glucose level ≥ 5.6 mmol/L and/
or current use of antihyperglycemic medication; (4) 
HDL-C  <  1.0  mmol/L for men and <1.3  mmol/L for 
women; and (5) serum TGs ≥ 1.7 mmol/L.
A BMI ≥  28  kg/m2 was defined as obesity, as recom-
mended for Asians by WHO experts (Mi et al. 2015), and 
a BMI < 28 kg/m2 was defined as non-obesity. We used 
this definition alongside data on Mes to create four phe-
notypes: metabolically healthy non-obesity (MHNO), 
metabolically unhealthy non-obesity (MUNO), metaboli-
cally healthy obesity (MHO) or metabolically unhealthy 
obesity (MUO).
For the stratification analysis based on different BMI 
group, consistent with the lower cut-off values recom-
mended by WHO experts for Asians (Mi et al. 2015), we 
used the BMI to define underweight (<18.5 kg/m2), nor-
mal weight (18.5–23.9  kg/m2), overweight (24–27.9  kg/
m2) and obesity (≥28  kg/m2), with the under 18.5 cate-
gory (n = 257) removed from the analysis.
The occurrence of ischemic stroke was determined 
by an epidemiological questionnaire and was defined as 
a history of cerebrovascular events, as demonstrated by 
either cranial CT or MR scan (within the past 24 months 
before inclusion).
Statistical analysis
As described in detail previously (Yu et al. 2014; Chang 
et  al. 2016), descriptive statistics were calculated for all 
variables, including continuous variables (expressed 
as the mean and standard deviation) and categorical 
variables (expressed as numbers and proportions). Dif-
ferences among categories were evaluated using the t 
test, ANOVA, a non-parametric test or the χ2-test as 
appropriate. Comparisons between groups were per-
formed using Scheffe’s method. Multivariate logistic 
regression analyses were conducted to identify independ-
ent associations of different weights and metabolic sta-
tuses with ischemic stroke using different models, and 
odds ratios (ORs) and corresponding 95  % confidence 
intervals (CIs) were calculated. All statistical analyses 
were performed using SPSS version 22.0 software, and 
P values of less than 0.05 were considered statistically 
significant.
Results
Baseline characteristics of participants according 
to different obesity phenotypes
A total of 11,150 participants were evaluated in this 
cross-sectional study. The prevalence rates of the dif-
ferent obesity types were 59.4 % for MHNO, 32.8 % for 
MUNO, 1.7 % for MHO and 6.1 % for MUO. Among the 
obese population, the prevalence of MHO was 21.8  %. 
There were significant differences in age, gender, race, 
education level, physical activity, annual income, current 
smoking status, sleep duration, systolic blood pressure, 
diastolic blood pressure, body mass index (BMI) waist 
circumference (WC), low-density lipoprotein cholesterol 
(LDL), high-density lipoprotein cholesterol (HLDL), tri-
glycerides (TGs), and total cholesterol (TC) among our 
study groups (Table 1) (all P < 0.05).
Characteristics of participants with or without ischemic 
stroke
The results presented in Table  2 show that the subjects 
with ischemic stroke were significantly older and had a 
significantly higher BMI, WC, systolic blood pressure, 
diastolic blood pressure, and fasting plasma glucose, 
LDL, TC, and TG levels and a lower HDL level than those 
without stroke (all P < 0.001). In addition, a significantly 
higher number of subjects with ischemic stroke had a 
lower education level, annual income and physical activ-
ity level (all P  <  0.001). However, there were no signifi-
cant differences in race, sleep duration, mean weight or 
salt intake.
The prevalence of ischemic stroke according 
to different obesity phenotypes
The prevalence of ischemic stroke in our study was 3.2 % 
(Table 2). As shown in Fig. 1, the prevalence of ischemic 
stroke among the total population was significantly 
increased for MUNO (4.9 %) and MUO (4.8 %) and was 
decreased for MHNO (2.0  %) and MHO (1.7  %). As 
shown in Fig. 2, among the females, the MUO group had 
the highest prevalence of ischemic stroke (5.6 %), and the 
MHNO group had the lowest prevalence (1.4  %) com-
pared with the other three groups (p < 0.001); however, 
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among the males, the MUNO group had the highest 
prevalence of ischemic stroke (4.9  %), and the MHO 
group had the lowest prevalence (1.4 %) (p < 0.001).
Multiple regression analyses of ischemic stroke 
and obesity phenotypes
As shown in Table 3, multiple regression analyses of the 
total population adjusted for age, race, gender, education 
level, annual income, current smoking status, current 
drinking status, diet score, salt intake, physical activity, 
and sleep duration showed that the subjects with MUNO 
and MUO were more likely to experience ischemic stroke 
than those with MHNO (OR 2.136, 95 % CI 1.677–2.720; 
OR 2.712, 95  % CI 1.798–4.092; all p  <  0.001). How-
ever, multiple regression analyses by gender showed 
minor different results. Among the male population, 
after adjusting for the same factors mentioned above, 
the subjects with MUNO were more likely to experi-
ence ischemic stroke than those with MHNO (OR 1.855, 
95  % CI 1.312–2.622; p  <  0.001); MUO males also had 
a higher OR for ischemic stroke than MHNO males, 
but the difference wasn’t significant (OR 1.842, 95 % CI 
0.888–3.819; p = 0.101); compared with MHNO, the OR 
for ischemic stroke in MHO males was lower, but the 
Table 1 Baseline characteristics of the study population according to different obesity phenotypes
Data are expressed as the mean ± SD or as n (%)
CNY China Yuan (1CNY = 0.157 USD), BMI body mass index, WC waist circumference, SBP systolic blood pressure, DBP diastolic blood pressure, FPG fasting plasma 
glucose, TC total cholesterol, TGs triglycerides, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol
Variables MHNO MHO MUNO MUO P
n (%) 6620 (59.4) 184 (1.7) 3666 (32.8) 680 (6.1)
Age (year) 52.9 ± 10.7 49.7 ± 9.6 55.9 ± 10.2 52.9 ± 9.9 <0.001
Race 0.002
Han 6264 (94.6) 172 (93.5) 3517 (96.0) 632 (92.9)
Othera 356 (5.4) 12 (6.5) 149 (4.0) 48 (7.1)
Current smoking status 2584 (39.0) 33 (17.9) 1123 (30.6) 178 (26.2) <0.001
Current drinking status 1696 (25.6) 32 (17.4) 640 (17.5) 128 (18.8) <0.001
Sleep duration (h/d) 7.3 ± 1.7 7.6 ± 1.5 7.2 ± 1.8 7.3 ± 1.6 0.004
TC (mmol/L) 5.1 ± 1.0 5.2 ± 0.9 5.5 ± 1.2 5.5 ± 1.3 <0.001
TGs (mmol/L) 1.2 ± 0.8 1.2 ± 0.6 2.4 ± 1.9 2.5 ± 2.2 <0.001
HDL-C (mmol/L) 1.5 ± 0.4 1.4 ± 0.3 1.2 ± 0.3 1.2 ± 0.3 <0.001
LDL-C (mmol/L) 2.8 ± 0.8 3.1 ± 0.8 3.1 ± 0.9 3.3 ± 0.9 <0.001
FPG (mmol/L) 5.5 ± 1.1 5.3 ± 0.6 6.5 ± 2.1 6.5 ± 2.0 <0.001
SBP (mmHg) 135.8 ± 22.1 138.7 ± 21.7 150.1 ± 22.5 153.9 ± 22.8 <0.001
DBP (mmHg) 79.3 ± 11.1 81.8 ± 11.3 85.7 ± 11.5 88.8 ± 11.7 <0.001
Mean height 161.1 ± 8.0 157.7 ± 10.7 159.8 ± 8.3 160.4 ± 8.4 <0.001
Mean weight 60.4 ± 9.4 81.6 ± 10.2 66.1 ± 9.8 83.2 ± 10.2 <0.001
WC (cm) 78.0 ± 7.9 95.4 ± 9.2 86.6 ± 7.3 99.0 ± 7.9 <0.001
BMI (kg/m2) 23.2 ± 2.7 33.0 ± 4.5 25.8 ± 2.5 32.2 ± 2.2 <0.001
Diet score 2.4 ± 1.1 2.3 ± 1.0 2.2 ± 1.1 2.3 ± 1.2 <0.001
Salt intake 6.4 ± 3.8 6.1 ± 3.6 6.5 ± 3.8 6.4 ± 3.9 0.099
Educational level (%) <0.001
 Primary school or below 3080 (46.5) 80 (43.5) 2086 (56.9) 329 (48.4)
 Middle school 2919 (44.1) 86 (46.7) 1267 (34.6) 278 (40.9)
 High school or above 621 (9.4) 18 (9.8) 313 (8.5) 73 (10.7)
Physical activity (%) <0.001
 Light 1737 (26.2) 40 (21.7) 1296 (35.4) 224 (32.9)
 Moderate 4533 (68.5) 136 (73.9) 2130 (58.1) 414 (60.9)
 Severe 350 (5.3) 8 (4.3) 240 (6.5) 42 (6.2)
Annual income (CNY/year) 0.045
 ≤5000 809 (12.2) 23 (12.5) 499 (13.6) 61 (9.0)
 5000–20,000 3629 (54.8) 100 (54.3) 1959 (53.4) 391 (57.5)
 >20,000 2182 (33.0) 61 (33.2) 1208 (33.0) 228 (33.5)
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difference was not significant, either(OR 0.782, 95 % CI 
0.100–5.642; p =  0.782). Among the female population, 
multiple regression analyses adjusted for the same factors 
mentioned above revealed that females with MUNO and 
MUO were more likely to experience ischemic stroke 
than females with MHNO (for MUNO, OR 2.528, 95 % 
CI 1.762–3.626; for MUO, OR 3.592, 95  % CI 2.117–
6.094; all p  <  0.001); in addition, the OR for ischemic 
stroke did not significantly differ between females with 
MHO and females with MHNO.
Results from stratification based on different BMI group
As shown in Table 4, for both males and females, people 
who had Mes with normal weight had higher prevalence 
of ischemic stroke than those who were normal weight 
but did not have Mes (both p < 0.05). Similarly, For all the 
participants, people who had Mes with overweight had 
higher prevalence of ischemic stroke than those who were 
overweight without (both p  <  0.05). The female partici-
pants with obesity and Mes had significantly higher OR for 
ischemic stroke than those who were obesity without Mes 
(p < 0.05). The male participants with obesity and Mes had 
higher OR for ischemic stroke than those who were obe-
sity without Mes, but the difference was not significantly.
As shown in Table  3, compared with those who were 
normal weight without MeS, after adjusting for the same 
factors mentioned above, participants who had Mes with 
overweight or obesity had significantly higher OR for 
ischemic stroke (all p  <  0.05); Participants who didn’t 
have Mes in overweight or obesity also higher OR for 
ischemic stroke, but the difference was not significant.
Discussion
The main finding of this study was that individuals with 
MUO or MUNO were more likely to experience ischemic 
stroke than those with MHNO, and differences were 
observed between the genders.
This is the first study to investigate the prevalence rates 
of ischemic stroke among different  obesity phenotypes 
Table 2 Characteristics of study participants with or with-
out ischemic stroke
Data are expressed as the mean ± SD or as n (%)
CNY China Yuan (1CNY = 0.157 USD), BMI body mass index, WC waist 
circumference, SBP systolic blood pressure, DBP diastolic blood pressure, FPG 
fasting plasma glucose, TC total cholesterol, TGs triglycerides, LDL-C low-density 
lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol
Variables Ischemic stroke
Yes No P
n (%) 353 (3.2) 10,797 (96.8)
Age (year) 63.3 ± 8.5 53.5 ± 10.5 <0.001
Race 0.443
Han 332 (94.1) 10,253 (95.0)
Othera 21 (5.9) 544 (5.0)
Current smoking status 106 (30.0) 3812 (35.3) 0.041
Current drinking status 41 (11.6) 2455 (22.7) <0.001
Sleep duration (h/d) 7.1 ± 2.1 7.3 ± 1.7 0.122
TC (mmol/L) 5.4 ± 1.0 5.2 ± 1.1 0.001
TGs (mmol/L) 2.1 ± 1.9 1.6 ± 1,5 <0.001
HDL-C (mmol/L) 1.3 ± 0.4 1.4 ± 0.4 <0.001
LDL-C (mmol/L) 3.2 ± 0.8 2.9 ± 0.8 <0.001
FPG (mmol/L) 6.5 ± 2.1 5.9 ± 1.6 <0.001
SBP (mmHg) 160.5 ± 27.0 141.0 ± 23.0 <0.001
DBP (mmHg) 86.9 ± 11.9 81.9 ± 11.7 <0.001
Mean height 158.4 ± 8.0 160.6 ± 8.2 <0.001
Mean weight 63.9 ± 10.3 64.1 ± 11.4 0.784
WC (cm) 85.6 ± 9.4 82.3 ± 9.8 <0.001
BMI (kg/m2) 25.4 ± 3.6 24.8 ± 3.7 0.001
Diet score 1.9 ± 1.2 2.3 ± 1.1 <0.001
Salt intake 6.7 ± 3.9 6.4 ± 3.7 0.23
Educational level (%) <0.001
 Primary school or below 245 (69.4) 5330 (49.4)
Fig. 1 The prevalence of ischemic stroke among the total population
Fig. 2 The prevalence of ischemic stroke for different groups by 
gender
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using the ATP-III criteria for defining metabolic health. 
Previous studies have examined the associations of dif-
ferent obesity  phenotypes with diabetes and CVD. 
Researchers reported that compared with metabolically 
healthy, normal-weight individuals, MHO individuals are 
more likely to have metabolic risk factors and incident 
diabetes but not CVD/stroke after several years of follow-
up (Appleton et al. 2013). In our study, we similarly found 
that MHO was not associated with an increased preva-
lence of ischemic stroke; however, Sarah did not analyze 
the other obesity phenotypes, such as MUO. Hinnouho 
et  al. analyzed the risks of cardiovascular disease and 
type 2 diabetes in individuals with different body mass 
indexes and metabolic health statuses. They reported that 
the MHO phenotype is associated with lower risk of type 
2 diabetes than the metabolically unhealthy obese phe-
notype but that the risk of CVD is equally elevated for 
both obesity phenotypes (Hinnouho et  al. 2015). In our 
study, we obtained different results, finding that not only 
MUO but also MUNO were associated with an increased 
prevalence of ischemic stroke among the total popula-
tion. However, Hinnouho et al. did not conduct separate 
subgroup analysis of ischemic stroke.
In order to confirm the effect by Mes, we did stratification 
based on different BMI group. Results showed that, com-
pared with people who were normal weight without Mes, 
participants who were in Mes with overweight or obesity 
had significantly higher OR for ischemic stroke; partici-
pants who were not in Mes with overweight or obesity did 
not showed OR significantly higher. These results evidenced 
that it was Mes increased the risk for ischemic stroke.
Previous study indicated many factors could associ-
ated with ischemic stroke such as age, smoking, excessive 
drinking including BMI (Long et  al. 2016; Al-Rubeaan 
et  al. 2016). However, after adjusted the related factors 
mentioned above, our study still confirm it was metabolic 
abnormalities not BMI itself increase the risk of ischemic 
stroke.
Some studies have examined the mechanisms of the 
association with CVD with obesity phenotypes. Karuna-
karan Indulekha et  al. have analyzed the associations 
of adipokines and inflammatory and oxidative stress 
markers with obesity phenotypes. They have found that 
the metabolically obese phenotype is characterized by 
Table 3 Multiple logistic regression analyses for ischemic stroke
OR odds ratio, 95 % CI 95 % confidence interval, MHO metabolically healthy obesity, MHNO metabolically healthy non-obesity, MUNO metabolically unhealthy non-
obesity, MUO metabolically unhealthy obesity, Mes metabolic syndrome
p < 0.05 was considered to be significant and typed in italics
Total Males Females
OR (95 % CI) p OR (95 % CI) p OR (95 % CI) p
Grouped by Mes and obesitya
MHNO 1.000 (reference) 1.000 (reference) 1.000 (reference)
MHO 1.121 (0.348–3.615) 0.848 0.752 (0.100–5.642) 0.782 1.651 (0.389–7.012) 0.497
MUNO 2.136 (1.677–2.720) <0.001 1.855 (1.312–2.622) <0.001 2.528 (1.762–3.626) <0.001
MUO 2.712 (1.798–4.092) <0.001 1.842 (0.888–3.819) 0.101 3.592 (2.117–6.094) <0.001
Grouped by BMI and Mesb
Normal weight and no MeS 1.000 (reference) 1.000 (reference) 1.000 (reference)
Normal weight and MeS 1.843 (0.946–3.592) 0.072 2.256 (1.269–4.011) 0.006 1.943 (1.289–2.930) 0.002
Overweight and no MeS 1.209 (0.755–1.934) 0.429 1.571 (0.817–3.022) 0.176 1.319 (0.903–1.928) 0.152
Overweight and MeS 1.975 (1.241–3.143) 0.004 2.920 (1.779–4.791) <0.001 2.344 (1.695–3.241) <0.001
Obesity and no MeS 1.559 (0.642–3.787) 0.327 1.602 (0.540–4.750) 0.395 1.510 (0.762–2.993) 0.238
Obesity and MeS 2.166 (1.282–3.659) 0.004 3.964 (2.373–6.621) <0.001 2.898 (2.051–4.094) <0.001
Table 4 Prevalence of  ischemic stroke according to differ-
ent BMI group by Mes or not
Mes Metabolic syndrome
Prevalence of ischemic stroke
no Mes Mes P
Total
Normal weight 73 (1.9 %) 41 (5.1 %) <0.001
Overweight 48 (2.2 %) 95 (4.8 %) <0.001
Obesity 10 (2.1 %) 73 (5.0 %) 0.005
Male
Normal weight 50 (2.6 %) 13 (5.6 %) 0.009
Overweight 32 (2.7 %) 34 (4.6 %) 0.022
Obesity 6 (2.7 %) 24 (3.9 %) 0.384
Female
Normal weight 23 (1.3 %) 28 (4.8 %) <0.001
Overweight 16 (1.6 %) 61 (4.9 %) <0.001
Obesity 4 (1.5 %) 49 (5.8 %) 0.005
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altered adipokine and inflammatory profiles, which could 
indicate that individuals with this phenotype are at high 
risk of type 2 diabetes mellitus and cardiovascular disease 
(Karunakaran et al. 2015). Scott Ahl et al. have reported 
that ADPN is associated with better metabolic health in 
both non-obese  and  obese  white individuals. They have 
concluded that ADPN and peripheral adiposity play key 
roles in determining metabolic health, independent of 
BMI (Ahl et al. 2015). However, the mechanisms under-
lying the relationships between stroke and the different 
obesity phenotypes require further targeted research.
In addition, there is a novel result of our study. Among 
the females, the MUO group had the highest preva-
lence of ischemic stroke, whereas among the males, 
the MUNO group had the highest prevalence. Moreo-
ver, multiple regression analyses by gender showed that 
ischemic stroke was more likely to affect the males with 
MUNO, whereas it was more likely to affect the females 
with MUNO or MUO. These results indicate that metab-
olism and not obesity itself causes CVD, in agreement 
with other studies (Millan-Nunez et al. 2016; Stojanović 
et  al. 2015; Turker et  al. 2015). However, the differing 
results according to gender require further investigation. 
According to previous studies, the effects of hormones 
should be considered because estrogen in women is 
known to be associated with adipocytes function (Frank-
enfeld et al. 2004; Tworoger et al. 2004; Luo et al. 2003).
Our study has some limitations. First, it is a cross-
sectional study; thus, we could not distinguish between 
cause and effect, and further longitudinal study should 
be conducted to verify our conclusions. Second, the defi-
nition for obesity and unhealthy metabolism was based 
on criteria for Asians by WHO and ATP-III components 
respectively, so they could not be representative glob-
ally. Finally, we used BMI as a criterion for obesity, but 
BMI only describes overall body mass and does not dis-
tinguish between fat and muscle or differentiate among 
different fat distributions. We also used WC, which is a 
better representation of metabolic abnormalities, as an 
indicator of obesity-related metabolic abnormalities.
Conclusions
Our findings indicate that ischemic stroke is likely related 
to poor metabolic health rather than to obesity itself. 
Thus, controlling metabolic abnormalities may be an 
effective way to decrease the risk of ischemic stroke. Fur-
thermore, particularly for males, greater consideration 
should be given to those in the metabolically unhealthy 
non-obesity category.
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